55 studies found for:    Open Studies | "Niacin"
Show Display Options
Rank Status Study
21 Recruiting A Study Investigating the Effects of Niagen™ in Healthy Adults.
Condition: Bioavailability
Interventions: Dietary Supplement: Niagen™ 100;   Dietary Supplement: Niagen™ 300;   Dietary Supplement: Niagen™ 1000;   Other: Placebo
22 Recruiting Lao Zinc Study: Effects of Two Forms of Daily Preventive Zinc Versus Therapeutic Zinc Supplementation
Condition: Diarrhea
Interventions: Dietary Supplement: MNP;   Dietary Supplement: preventive zinc supplement;   Dietary Supplement: therapeutic zinc supplement;   Dietary Supplement: preventive placebo supplement;   Dietary Supplement: therapeutic placebo supplement;   Dietary Supplement: placebo powder
23 Recruiting A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.
Condition: Cardiovascular Diseases
Interventions: Drug: AMR101;   Drug: Placebo
24 Unknown  A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES)
Condition: Schizophrenia
Intervention:
25 Recruiting Multi-micronutrient Supplementation During Peri-conception and Congenital Heart Disease
Condition: Congenital Heart Disease
Interventions: Dietary Supplement: Vitamin B Complex and Folic Acid;   Dietary Supplement: Iron and Folic Acid;   Dietary Supplement: Folic Acid
26 Unknown  Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex
Conditions: Lack of Appetite;   Anorexia
Interventions: Drug: Apevinat BC;   Drug: Vitamin Complex
27 Recruiting Iron Absorption From a Micronutrient Powder Containing Galacto-oligosaccharides (GOS)
Condition: Anemia, Iron-Deficiency
Interventions: Dietary Supplement: Fortified maize porridge (MNP+iron);   Dietary Supplement: Fortified maize porridge (MNP+iron+GOS)
28 Recruiting Comparison of Two Nutrition Interventions in Young Children in El Salvador
Condition: Micronutrient Deficiency
Interventions: Dietary Supplement: 21 micronutrient-fortified supplement;   Dietary Supplement: Cereal Fortificado (Fortified Cereal);   Dietary Supplement: Ferrous sulphate;   Dietary Supplement: Vitamin A
29 Recruiting A Study to Evaluate Safety and Health Benefits of Basis™ Among Elderly Subjects.
Condition: Safety: Healthy Subjects
Interventions: Dietary Supplement: Basis 250;   Dietary Supplement: Basis 500;   Dietary Supplement: Placebo
30 Unknown  Prostate Cancer Prevention Trial With Quercetin and Genistein
Condition: Primary Prevention of Prostate Cancer
Interventions: Dietary Supplement: Quercetin supplement;   Dietary Supplement: Genistein supplement;   Dietary Supplement: Placebo
31 Recruiting Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Condition: Hyperlipidemia
Intervention: Drug: ARI-3037MO
32 Unknown  Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases
Conditions: Preeclampsia;   Pregnancy;   Micronutrients;   Exercise
Interventions: Behavioral: Regular aerobic physical exercise;   Dietary Supplement: Micronutrients;   Other: Activities of daily living + placebo
33 Not yet recruiting Filgrastim, Cladribine, Cytarabine and Mitoxantrone With or Without Sorafenib Tosylate in Treating Patients With Newly-Diagnosed, High-Risk Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: Acute Biphenotypic Leukemia;   Acute Myeloid Leukemia;   de Novo Myelodysplastic Syndrome;   Myeloproliferative Neoplasm
Interventions: Drug: Cladribine;   Drug: Cytarabine;   Biological: Filgrastim;   Other: Laboratory Biomarker Analysis;   Drug: Mitoxantrone Hydrochloride;   Other: Quality-of-Life Assessment;   Drug: Sorafenib Tosylate
34 Recruiting Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
Conditions: Recurrent Hepatocellular Carcinoma;   Solid Neoplasm;   Stage IV Hepatocellular Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Navitoclax;   Other: Pharmacological Study;   Drug: Sorafenib Tosylate
35 Recruiting Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Conditions: Advanced Adult Hepatocellular Carcinoma;   Localized Non-Resectable Adult Hepatocellular Carcinoma;   Stage III Childhood Hepatocellular Carcinoma;   Stage IIIA Hepatocellular Carcinoma;   Stage IIIB Hepatocellular Carcinoma;   Stage IIIC Hepatocellular Carcinoma;   Stage IV Childhood Hepatocellular Carcinoma;   Stage IVA Hepatocellular Carcinoma;   Stage IVB Hepatocellular Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Sorafenib Tosylate
36 Recruiting Sorafenib Tosylate, Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With High-Risk Stage IIB-IV Soft Tissue Sarcoma
Conditions: Stage IIB Adult Soft Tissue Sarcoma;   Stage III Adult Soft Tissue Sarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Drug: Epirubicin Hydrochloride;   Radiation: External Beam Radiation Therapy;   Drug: Ifosfamide;   Other: Laboratory Biomarker Analysis;   Drug: Sorafenib Tosylate;   Procedure: Therapeutic Conventional Surgery
37 Recruiting Sorafenib Tosylate, Valproic Acid, and Sildenafil Citrate in Treating Patients With Recurrent High-Grade Glioma
Conditions: Brain and Nervous System;   Glioblastoma;   Glioma
Interventions: Drug: sorafenib tosylate;   Drug: valproic acid;   Drug: sildenafil citrate
38 Recruiting Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Localized Resectable Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer
Interventions: Drug: sorafenib tosylate;   Other: placebo;   Other: laboratory biomarker analysis
39 Recruiting Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia
Condition: Adult Acute Myeloid Leukemia in Remission
Interventions: Procedure: Bone Marrow Transplantation;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Sorafenib Tosylate
40 Recruiting Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions: Leukemia Cutis;   Myeloid Sarcoma;   Untreated Adult Acute Myeloid Leukemia;   Untreated Childhood Myeloid Neoplasm
Interventions: Drug: Asparaginase;   Drug: Bortezomib;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Drug: Mitoxantrone Hydrochloride;   Other: Pharmacological Study;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Drug: Sorafenib Tosylate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-55) Show next page of results    Last Page
Indicates status has not been verified in more than two years